Legions Of Life Scientists Will Be Called To The Front, As War On AIDS Intensifies

With the pandemic mounting and no sure remedies in sight, experts foresee the growing recruitment of skilled researchers On May 21, the World Health Organization announced that 14 million people have been infected with HIV so far, and the global figure could hit 40 million by the year 2000. And the ninth international AIDS meeting in Berlin earlier this month yielded little startling information beyond the general agreement among scientists that they have been, in effect, stymied thus f

Written byRicki Lewis
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

With the pandemic mounting and no sure remedies in sight, experts foresee the growing recruitment of skilled researchers

But science's pursuit of a magic bullet--or arsenal of heavy artillery--to battle the scourge is picking up speed. And, while fundamental questions about AIDS remain unanswered, preparation for vaccine trials is under way worldwide, and the need for scientists in AIDS research will skyrocket, experts from diverse fields agree.

Although a precise counting of AIDS researchers is nearly impossible, the number is probably in the tens of thousands, according to several estimates and extrapolations. "For fiscal 1992, 1,894 principal investigators were on [National Institutes of Health] AIDS-related grants and contracts," says Robert Eisinger, senior program analyst in NIH's Office of AIDS Research. That support amounted to more than $1 billion of the agency's $10.3 billion 1992 budget, with $450 million going to the National Institute of Allergy and Infectious Diseases (NIAID).

When ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies